NADAC acquisition cost data for AMITRIPTYLINE HCL 25 MG TAB. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Amitriptyline HCL |
| Brand Name | Amitriptyline HCL |
| Manufacturer | Direct_rx |
| Dosage Form | TABLET |
| Route | ORAL |
| Pharmacologic Class | Tricyclic Antidepressant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00603221321 | $0.0515 | 2022-12-21 | Rx |
| 00603221332 | $0.0515 | 2022-12-21 | Rx |
| 00781148701 | $0.0515 | 2022-12-21 | Rx |
| 00781148710 | $0.0515 | 2022-12-21 | Rx |
| 00904020161 | $0.0515 | 2022-12-21 | Rx |
| 00904718461 | $0.0515 | 2022-12-21 | Rx |
| 16714025801 | $0.0515 | 2022-12-21 | Rx |
| 16714025802 | $0.0515 | 2022-12-21 | Rx |
| 16714044701 | $0.0515 | 2022-12-21 | Rx |
| 16714044702 | $0.0515 | 2022-12-21 | Rx |
Generic: Amitriptyline HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $88.5M | 3,588,992 | 796,889 | $0.3925 |
| 2020 | $88.0M | 3,728,901 | 806,659 | $0.3692 |
| 2021 | $83.4M | 3,685,675 | 831,271 | $0.3489 |
| 2022 | $80.6M | 3,633,608 | 827,213 | $0.3349 |
| 2023 | $74.1M | 3,644,206 | 838,449 | $0.3054 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.